CLGNCollPlant Biotechnologies Ltd

Nasdaq collplant.com


$ 4.93 $ -0.03 (-0.6 %)    

Friday, 28-Jun-2024 11:45:14 EDT
QQQ $ 479.98 $ -2.50 (-0.52 %)
DIA $ 391.11 $ -0.43 (-0.11 %)
SPY $ 544.70 $ -2.15 (-0.39 %)
TLT $ 91.77 $ -1.74 (-1.86 %)
GLD $ 215.03 $ 0.02 (0.01 %)
$ 4.97
$ 4.93
$ 0.00 x 0
$ 0.00 x 0
$ 4.93 - $ 4.93
$ 4.22 - $ 8.30
2,091
na
56.92M
$ 0.85
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 collplant-reports-successful-bio-printing-of-200cc-breast-implants-and-additional-pre-clinical-data

Bio-printing technology now enables fabrication of 200cc implant size and above to address future commercial demand Interim ...

 hc-wainwright--co-reiterates-buy-on-collplant-biotechnologies-maintains-11-price-target

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates CollPlant Biotechnologies (NASDAQ:CLGN) with a Buy and mai...

 collplant-biotechnologies-q1-adj-035-inline-sales-9800k-miss-60000k-estimate

CollPlant Biotechnologies (NASDAQ:CLGN) reported quarterly losses of $(0.35) per share which met the analyst consensus estimate...

 hc-wainwright--co-reiterates-buy-on-collplant-biotechnologies-maintains-11-price-target

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates CollPlant Biotechnologies (NASDAQ:CLGN) with a Buy and mai...

 collplant-biotechnologies-q4-adj-eps-035-misses-007-estimate-sales-29900k-miss-856m-estimate

CollPlant Biotechnologies (NASDAQ:CLGN) reported quarterly Adj losses of $(0.35) per share which missed the analyst consensus e...

 earnings-scheduled-for-april-4-2024

Companies Reporting Before The Bell • Conagra Brands (NYSE:CAG) is likely to report quarterly earnings at $0.65 per share on r...

 collplant-biotechnologies-issues-letter-to-shareholders

Dear Shareholders,As we look toward a promising and exciting year ahead, I am proud to reflect on CollPlant's main achievem...

 collplant-biotechnologies-begins-preclinical-trial-with-commercial-size-regenerative-breast-implants

CollPlant Biotechnologies (NASDAQ:CLGN), a regenerative and aesthetics medicine company developing innovative technologies and ...

 hc-wainwright--co-reiterates-buy-on-collplant-biotechnologies-maintains-11-price-target

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates CollPlant Biotechnologies (NASDAQ:CLGN) with a Buy and mai...

 earnings-scheduled-for-november-29-2023

Companies Reporting Before The Bell • CollPlant Biotechnologies (NASDAQ:CLGN) is likely to report quarterly loss at $0.13 per ...

 collplant-biotechnologies-q3-adj-eps-035-misses-013-estimate-sales-4300k-miss-350m-estimate

CollPlant Biotechnologies (NASDAQ:CLGN) reported quarterly adjusted losses of $(0.35) per share which missed the analyst consen...

 hc-wainwright--co-reiterates-buy-on-collplant-biotechnologies-maintains-11-price-target

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates CollPlant Biotechnologies (NASDAQ:CLGN) with a Buy and mai...

 collplant-biotechnologies-q2-adjusted-eps-052-beats-001-estimate-sales-1018m-beat-515m-estimate

CollPlant Biotechnologies (NASDAQ:CLGN) reported quarterly earnings of $0.52 per share which beat the analyst consensus estimat...

 earnings-scheduled-for-august-24-2023

Companies Reporting Before The Bell • 111 (NASDAQ:YI) is estimated to report earnings for its second quarter.